# Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People

> **NCT00065377** · PHASE1 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 60 (—)

## Conditions studied

- Obesity
- Insulin Resistance

## Interventions

- **DRUG:** Glucosamine Hydrochloride

## Key facts

- **NCT ID:** NCT00065377
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00065377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00065377, "Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00065377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*